Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1997 1
1998 2
2003 1
2014 1
2016 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function.
Dickinson JL, Bates EJ, Ferrante A, Antalis TM. Dickinson JL, et al. J Biol Chem. 1995 Nov 17;270(46):27894-904. doi: 10.1074/jbc.270.46.27894. J Biol Chem. 1995. PMID: 7499264 Free article.
Plasminogen activator inhibitor type 2 (PAI-2) is a serine proteinase inhibitor or serpin that is a major product of macrophages in response to endotoxin and inflammatory cytokines. We have explored the role of PAI-2 in apop
Plasminogen activator inhibitor type 2 (PAI-2) is a serine proteinase inhibitor or serpin t
Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.
Dear AE, Shen Y, Rüegg M, Medcalf RL. Dear AE, et al. Eur J Biochem. 1996 Oct 1;241(1):93-100. doi: 10.1111/j.1432-1033.1996.0093t.x. Eur J Biochem. 1996. PMID: 8898893 Free article.
Plasminogen-activator inhibitor type 2 (PAI-2), a serine protease inhibitor involved in the regulation of urokinase-dependent proteolysis, is also implicated in the inhibition of tumor-necrosis-factor-(T
Plasminogen-activator inhibitor type 2 (PAI-2), a serine protease inhibitor involved in the
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
Dickinson JL, Norris BJ, Jensen PH, Antalis TM. Dickinson JL, et al. Cell Death Differ. 1998 Feb;5(2):163-71. doi: 10.1038/sj.cdd.4400324. Cell Death Differ. 1998. PMID: 10200461
The serine proteinase inhibitor (serpin), plasminogen activator inhibitor type 2 (PAI-2), has been reported to inhibit tumor necrosis factor-alpha (TNF) induced apoptosis. ...The PAI …
The serine proteinase inhibitor (serpin), plasminogen activator inhibitor type 2 (PAI-2), h …
The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming.
Antalis TM, La Linn M, Donnan K, Mateo L, Gardner J, Dickinson JL, Buttigieg K, Suhrbier A. Antalis TM, et al. J Exp Med. 1998 Jun 1;187(11):1799-811. doi: 10.1084/jem.187.11.1799. J Exp Med. 1998. PMID: 9607921 Free PMC article.
The serine proteinase inhibitor (serpin) plasminogen activator inhibitor type 2 (PAI-2) is well characterized as an inhibitor of extracellular urokinase-type plasminogen activator. ...These observations, …
The serine proteinase inhibitor (serpin) plasminogen activator inhibitor type 2 (PAI-2) is …
Brain-derived extracellular vesicles mediated coagulopathy, inflammation and apoptosis after sepsis.
Lin H, Chen H, Qi B, Jiang Y, Lian N, Zhuang X, Yu Y. Lin H, et al. Thromb Res. 2021 Sep 23;207:85-95. doi: 10.1016/j.thromres.2021.09.014. Online ahead of print. Thromb Res. 2021. PMID: 34583153 Free article.
Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of plasminogen activator inhibitor type 1 (PAI-1), thrombin-antithrombin (TAT), D-dimer, fibrinogen(Fib), tumor necrosis factor-alpha (TNF-alp
Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of plasminogen activator inhibitor ty
Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells.
Jänicke RU, Lee FH, Porter AG. Jänicke RU, et al. Mol Cell Biol. 1994 Sep;14(9):5661-70. doi: 10.1128/mcb.14.9.5661-5670.1994. Mol Cell Biol. 1994. PMID: 8065303 Free PMC article.
The phosphoprotein c-Myc has the potential to kill cells by apoptosis. To investigate whether c-Myc is involved in tumor necrosis factor alpha (TNF-alpha)-mediated cell killing, we have examined two HeLa cell lines (D98 and H21) which sho …
The phosphoprotein c-Myc has the potential to kill cells by apoptosis. To investigate whether c-Myc is involved in tumor ne
Is interferon gamma one key of metastatic potential increase in human bladder carcinoma?
Champelovier P, Simon A, Garrel C, Levacher G, Praloran V, Seigneurin D. Champelovier P, et al. Clin Cancer Res. 2003 Oct 1;9(12):4562-9. Clin Cancer Res. 2003. PMID: 14555531 Free article.
Because it acts in the anticancer process, we studied its cellular and molecular mechanisms of action on human bladder cancer cell lines. RESULTS: IFN-gamma (>5 ng.ml(-1))(>400 IU.ml(-1)) inhibited the growth of bladder cancer cell lines and modified the expression o …
Because it acts in the anticancer process, we studied its cellular and molecular mechanisms of action on human bladder cancer cell lines. RE …
Crebanine, an aporphine alkaloid, sensitizes TNF-alpha-induced apoptosis and suppressed invasion of human lung adenocarcinoma cells A549 by blocking NF-kappaB-regulated gene products.
Yodkeeree S, Pompimon W, Limtrakul P. Yodkeeree S, et al. Tumour Biol. 2014 Sep;35(9):8615-24. doi: 10.1007/s13277-014-1998-6. Epub 2014 May 28. Tumour Biol. 2014. PMID: 24867094
In this study, we investigated the effects of crebanine on tumor necrosis factor alpha (TNF-alpha)-induced NF-kappaB activation and the expression of NF-kappaB-regulated gene products. ...Moreover, crebanine reduced TNF-alpha-in
In this study, we investigated the effects of crebanine on tumor necrosis factor alpha (TNF-alpha)-ind
Suppression of PKC-alpha attenuates TNF-alpha-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system.
Abdullah Z, Bayraktutan U. Abdullah Z, et al. Biochim Biophys Acta. 2016 Jul;1862(7):1354-66. doi: 10.1016/j.bbadis.2016.03.014. Epub 2016 Apr 17. Biochim Biophys Acta. 2016. PMID: 27094771 Free article.
Using an in vitro model of human blood-brain barrier (BBB) composed of brain microvascular endothelial cells (HBMEC) and astrocytes, this study assessed the putative roles of these elements in BBB damage evoked by enhanced availability of pro-inflammatory cytokine, TNF-alpha
Using an in vitro model of human blood-brain barrier (BBB) composed of brain microvascular endothelial cells (HBMEC) and astrocytes, this st …
Intracellular calcium mobilization suppresses the TNF-alpha-stimulated synthesis of PAI-1 in human endothelial cells. Indications that calcium acts at a translational level.
Peiretti F, Alessi MC, Henry M, Anfosso F, Juhan-Vague I, Nalbone G. Peiretti F, et al. Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1550-60. doi: 10.1161/01.atv.17.8.1550. Arterioscler Thromb Vasc Biol. 1997. PMID: 9301635
We investigated in human umbilical vein endothelial cells (HUVECs) the interaction between the signaling pathways triggered by calcium mobilization and those affected by human recombinant tumor necrosis factor-alpha (TNF) on the expression of type
We investigated in human umbilical vein endothelial cells (HUVECs) the interaction between the signaling pathways triggered by calcium mobil …